You are here
,

Novartis strikes deal with Chinese firm to make Kymriah

  • Friday, 28 September 2018
  • Posted by Aftab Ahmad
  • 0 Comments
Novartis has enlisted Chinese manufacturer Cellular Biomedicine (CBMG) to make its $475,000 gene-modifying cancer treatment Kymriah as the Swiss drugmaker intends to win approval for the therapy in the world's most populous country.


from Reuters: Health News https://ift.tt/2DC6QsC

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply